— Know what they know.
Not Investment Advice

EPI.AX ASX

Epiminder Limited
1W: -10.3% YTD: -17.5%
A$0.27 ($0.18)
+0.01 (+1.92%)
 
ASX · Healthcare · Medical - Devices · A$56.3M mcap · 117M float · 0.170% daily turnover
Smart Money Score
No convergence signal
Key Statistics
Market CapA$56.3M ($39.2M)
52W Range0.25-1.49
Volume66,063
Avg Volume199,001
Beta2.71
Dividend—
Analyst Ratings
No analyst coverage
Company Info
CEORohan J. Hoare
SectorHealthcare
IndustryMedical - Devices
IPO Date2025-11-30
West Podium, Mezzanine 2
Melbourne, VIC 3000
AU
About Epiminder Limited

Epiminder Limited engages in the development and manufacture of monitoring device to improve treatment of patients suffering with epileptic seizures and related conditions. The company offers Minder system, an electroencephalographic (EEG) recording and transmitting device implanted under the scalp. Its Minder system comprises Minder Implant, a sub scalp electrode with multiple recording points which enables capture of EEG continuously for months or years; Minder Wearable, which receives and stores EEG recordings wirelessly transmitted from the Minder implant to the Minder app; Minder App that collects and transmits EEG data from the Minder implant via Bluetooth and uploads to the Minder Cloud for processing; and Minder Cloud, a secure, online portal which allows healthcare professionals to download patient data. The company was incorporated in 2017 and is based in Melbourne, Australia.

Latest News
No recent news

Recent Insider Trades

No insider trades found

Sign in to InsiderStreet

You'll also get our free weekly newsletter with
smart money signals, market insights, and alpha ideas.
Unsubscribe anytime.

For informational purposes only. Not investment advice. Data sourced from SEC filings. Privacy Terms